Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 18, 2021

SELL
$5.03 - $8.8 $1,006 - $1,760
-200 Closed
0 $0
Q4 2020

Feb 17, 2021

BUY
$4.04 - $5.31 $808 - $1,062
200 New
200 $0
Q3 2020

Nov 13, 2020

SELL
$3.64 - $7.76 $728 - $1,552
-200 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$4.78 - $8.26 $956 - $1,652
200 New
200 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $214M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.